← Leaderboards
Alastair J. J. Wood
Vanderbilt University
$1,021,454
Attributed
$1,021,454
Total exposure
10
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $131.7K · FY2005–06$200K$150K$100K$50K$0
'05
'06
Funding mix
By agency
NIH$20,013,723 · 11
By mechanism
M01$19,314,419 · 8
P01$408,470 · 2
R01$290,834 · 1
Top collaborators
No co-investigators on record.
Most similar at Vanderbilt University
Same institution · by research overlap
- Grant R. Wilkinson$1,933,364
- Richard B Kim$2,161,767
- Rose M Robertson$2,927,323
- Sabina Kupershmidt$3,007,448
Others in their field
Top investigators on “Human Subject”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- George R Seage · Abt Associates, Inc.$172,422,660
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$160,455,836
- Jeffrey P Krischer · University Of South Florida$155,493,283
- Charles A Coltman · Southwest Oncology Group$154,811,913
Research focus
Human SubjectClinical ResearchRacial /Ethnic DifferencePharmacokineticsVasodilationJapanese AmericanIsoproterenolCardiovascular PharmacologyCardiovascular FunctionPeripheral Nervous SystemHormone Regulation /Control MechanismAdrenergic AgentsCaucasian AmericanEstrogensHypoglycemic AgentsP GlycoproteinCytochrome P450High Performance Liquid ChromatographyDrug MetabolismEnzyme ActivityCaffeineDietary SodiumAfrican AmericanImmunocytochemistry
Grant awards (28)
PHYSIOLOGY AND PHARMACOLOGY OF A-ADRENERGIC RECEPTOR VARIABILITY$49,079
M01 · FY2006 · RR · contact PI
MDR-1-INHIBITION AND CYP3A ACTIVITY$14,262
M01 · FY2006 · RR · contact PI
EFFECT OF INHIBITION OF P-GLYCOPROTEIN BY XR-9576 ON THE CENTRAL OPIOID ACTIV$70,922
M01 · FY2005 · RR
PHYSIOLOGY AND PHARMACOLOGY OF A-ADRENERGIC RECEPTOR VARIABILITY$60,791
M01 · FY2005 · RR
General Clinical Research Center$5,615,681
M01 · FY2004 · RR
Physiology and Pharmacology of a-adrenergic Receptor Variability$78,679
M01 · FY2004 · RR
Effect of inhibition of P-glycoprotein by XR-9576 on the central opioid activ...$46,766
M01 · FY2004 · RR
Ethnicity and Vascular Reactivity$1,651
M01 · FY2004 · RR
General Clinical Research Center$4,615,510
M01 · FY2003 · RR
General Clinical Research Ctr Suppl-Immunology Core Lab$317,541
M01 · FY2003 · RR
GENERAL CLINICAL RESEARCH CENTER$4,701,714
M01 · FY2002 · RR
PHARMACOKINETICS OF ZOPOLRESTAT IN CAUCAS/JAPANESE$0
M01 · FY2002 · RR
ETHNICITY AND VASCULAR REACTIVITY$0
M01 · FY2002 · RR
Modulation of Human MDR1 Function In Vivo$0
P01 · FY2002 · GM
GENERAL CLINICAL RESEARCH CENTER$3,256,838
M01 · FY2001 · RR
GENERAL CLINICAL RESEARCH CENTER-GENETICS RESEARCH INIT$405,081
M01 · FY2001 · RR
CYTOCHROME P450 MEDIATED METABOLISM, DIET, AND THE GASTROINTESTINAL TRACT$140,822
P01 · FY2001 · GM
GCRC-MEDICAL SCHOLARS PROGRAM$79,904
M01 · FY2001 · RR
PHARMACOKINETICS OF ZOPOLRESTAT IN CAUCAS/JAPANESE$0
M01 · FY2001 · RR
PHARMACOKINETICS OF ZOPOLRESTAT IN CAUCAS/JAPANESE$0
M01 · FY2001 · RR
PHARMACOKINETICS OF ZOPOLRESTAT IN CAUCAS/JAPANESE$0
M01 · FY2001 · RR
ETHNICITY AND VASCULAR REACTIVITY$0
M01 · FY2001 · RR
ETHNICITY AND VASCULAR REACTIVITY$0
M01 · FY2001 · RR
ETHNICITY AND VASCULAR REACTIVITY$0
M01 · FY2001 · RR
ETHNIC DIFFERENCES IN AUTONOMIC CARDIOVASCULAR CONTROL$290,834
R01 · FY2000 · HL
CYTOCHROME P450 MEDIATED METABOLISM, DIET, AND THE GASTROINTESTINAL TRACT$267,648
P01 · FY2000 · GM
PHARMACOKINETICS OF ZOPOLRESTAT IN CAUCAS/JAPANESE$0
M01 · FY2000 · RR
ETHNICITY AND VASCULAR REACTIVITY$0
M01 · FY2000 · RR